Innovita Biological Technology Co., Ltd. (SHA:688253)
35.35
-0.04 (-0.11%)
At close: Jan 22, 2026
Innovita Biological Technology Company Description
Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products.
It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test.
The company was founded in 2006 and is based in Beijing, China.
Innovita Biological Technology Co., Ltd.
| Country | China |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 547 |
| CEO | Xiujie Zhang |
Contact Details
Address: Block 6 Beijing, 100070 China | |
| Phone | 86 10 8368 1277 |
| Website | innovita.com.cn |
Stock Details
| Ticker Symbol | 688253 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100005Q14 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Xiujie Zhang | GM and Director |
| Xiujuan Zhao | Financial Director and Director |
| Xiaogang Zhang | Deputy GM and Director |
| Fukang Chen | Board Secretary |
| Ying Zhao | Accounting Supervisor |